Long-acting reversible contraception: Placement, continuation, and removal rates at an inner-city academic medical center clinic

4Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Long-Acting Reversible Contraception (LARCs) has the potential to decrease unintended pregnancies but only if women can easily access a requested method. Retrospective electronic chart review identified women desiring LARC placement over a one-year period ending 31 December 2016. Most of the 311 insertions were for family planning, with 220 new insertions and 60 replace-ments. Delays occurred in 38% (n = 118) of patients, averaged 5 ± 5 weeks, and 47% received interval contraception. Reasons included absence of qualified provider (n = 44, 37%), pending cultures (n = 31, 26%), and Mirena availability. Teenage LARC use favored Nexplanon whereas older women preferred Mirena (p < 0.01). Of the 11% choosing early LARC removal, a significant number were African Americans (p = 0.040) or teenagers (p = 0.048). Retention time varied by device type; most patients switched to other contraceptives. No patients experienced IUD expulsion. Understanding barriers, attempting to remedy them, and addressing the side effects associated with LARC use is of importance in this inner-city patient population in the United States.

Cite

CITATION STYLE

APA

Runyan, A., Welch, R. A., Kramer, K. J., Cortez, S., Roberts, L. J., Asamoah, C., … Recanati, M. A. (2021). Long-acting reversible contraception: Placement, continuation, and removal rates at an inner-city academic medical center clinic. Journal of Clinical Medicine, 10(9). https://doi.org/10.3390/jcm10091918

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free